找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Rubidomycin; A New Agent against J. Bernard,R. Paul,R. Maral Book 1969 Springer-Verlag Berlin Heidelberg 1969 alkaloids.antibiotics.cancer

[復制鏈接]
查看: 49751|回復: 56
樓主
發(fā)表于 2025-3-21 18:54:18 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Rubidomycin
副標題A New Agent against
編輯J. Bernard,R. Paul,R. Maral
視頻videohttp://file.papertrans.cn/832/831999/831999.mp4
叢書名稱Recent Results in Cancer Research
圖書封面Titlebook: Rubidomycin; A New Agent against  J. Bernard,R. Paul,R. Maral Book 1969 Springer-Verlag Berlin Heidelberg 1969 alkaloids.antibiotics.cancer
描述Trials in the treatment of the leukemias are sometimes based on a hypothesis, as in the case of exchange transfusion [33] or the use of antimetabolites [86]. Or they are conducted empirically as the results of chance observations, as in the case of the use of the nitrogen mustards, urethane, and the Vinca alkaloids. Or they lie between the two, aiming at making use of well established biological facts: examples are the use of ACTH, cortisone and, more recently, the antibiotics. What is true for bacteria may also perhaps be true, if not for elephants, at least for the malignant cells of mammals. It was this idea that lay behind the first attempts at treating cancer and leukemia with antibiotics. The results obtained by the use of certain substances extracted from micro-organisms (actinomycin, azaserine, mito- mycin, rufocromomycin), although encouraging at times, were inconsistent. The action of rubidomycin appears to cover a wider spectrum and to be more consistent and more effective. As in the case of Homer and Christopher Columbus, the honor of having given birth to rubidomycin is claimed by more than one country and town. In fact, the same product was discovered in the same year
出版日期Book 1969
關鍵詞alkaloids; antibiotics; cancer; leukemia
版次1
doihttps://doi.org/10.1007/978-3-642-88125-1
isbn_softcover978-3-642-88127-5
isbn_ebook978-3-642-88125-1Series ISSN 0080-0015 Series E-ISSN 2197-6767
issn_series 0080-0015
copyrightSpringer-Verlag Berlin Heidelberg 1969
The information of publication is updating

書目名稱Rubidomycin影響因子(影響力)




書目名稱Rubidomycin影響因子(影響力)學科排名




書目名稱Rubidomycin網(wǎng)絡公開度




書目名稱Rubidomycin網(wǎng)絡公開度學科排名




書目名稱Rubidomycin被引頻次




書目名稱Rubidomycin被引頻次學科排名




書目名稱Rubidomycin年度引用




書目名稱Rubidomycin年度引用學科排名




書目名稱Rubidomycin讀者反饋




書目名稱Rubidomycin讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 23:46:00 | 只看該作者
板凳
發(fā)表于 2025-3-22 04:03:01 | 只看該作者
地板
發(fā)表于 2025-3-22 06:10:27 | 只看該作者
https://doi.org/10.1007/978-3-642-88125-1alkaloids; antibiotics; cancer; leukemia
5#
發(fā)表于 2025-3-22 10:14:41 | 只看該作者
6#
發(fā)表于 2025-3-22 14:55:41 | 只看該作者
History of RubidomycinAlthough short, the history of rubidomycin can be divided into three periods.
7#
發(fā)表于 2025-3-22 18:05:21 | 只看該作者
Biological ActivityThe choice of constituent A, i. e. rubidomycin, for use in chemotherapy [164, 165] was based on its greater stability, the fact that it could be obtained in the crystalline state [62] and, as found, in particular, with mice, its higher curative ratio; these factors more than outweighed its lower biological activity in absolute terms.
8#
發(fā)表于 2025-3-22 21:16:25 | 只看該作者
Fixation in the Cell and Mechanism of ActionExcept for recent papers by . et al., one of which [67] deals with the . investigation of its metabolization by tissue extracts, the other [65] with blood and urine determinations in the animals treated, no work has been published, as far as we know, on the analysis of rubidomycin in animal tissues.
9#
發(fā)表于 2025-3-23 01:36:53 | 只看該作者
10#
發(fā)表于 2025-3-23 07:54:54 | 只看該作者
PosologyRubidomycin can be used alone or in association with other drugs. The dose varies according to the disease and according to the stage of the disease, the details being given elsewhere for each of the main therapeutic indications. We shall confine ourselves here to some general remarks.
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 13:13
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
铁岭县| 余姚市| 阿勒泰市| 沙湾县| 福鼎市| 阳江市| 宁晋县| 木兰县| 阜阳市| 广水市| 驻马店市| 泸溪县| 西安市| 屏东县| 加查县| 亚东县| 康马县| 利津县| 抚顺市| 稷山县| 温泉县| 临洮县| 阳朔县| 伊宁市| 岳西县| 白银市| 邓州市| 志丹县| 马鞍山市| 景洪市| 梅河口市| 雷州市| 观塘区| 苏州市| 新宁县| 来凤县| 都昌县| 思南县| 县级市| 商洛市| 澄迈县|